Discover and read the best of Twitter Threads about #ODX

Most recents (10)

@johnredwood @JNHanvey @RichardNewby3 @emilydugan @SirRogerGale @sajidjavid #AVCT #ODX Here is the quickest solution for lateral flow test availability but will require asking some direct questions to those responsible for decisions making. I’m purposely not mentioning …1/15
…shambolic way the British industry was discriminated against their Chinese competitors, I will concentrate on immediate solutions and problems we can resolve ASAP:
1.) Since the beginning of the year, several British companies were in possession of the CE Mark for …2/15
…professional use only. These companies had lateral flow tests designed and made in UK. They were all well established and experienced in diagnostics and LFT manufacturing. @mologic #AVCT @AvactaDx @Omega_ODX #ODX were some of them. All these tests very heavily and …3/15
Read 19 tweets
This is the time @Omega_ODX @WalbrookPR #ODX where I would expect an official announcement from the BOD , open letter or RNS with all media cc stating” We are here, we have the test, we have the machines, we are ready!” That what confident proactive company would do yesterday!!
Unless @Omega_ODX @WalbrookPR there is something you not telling us like in the past when Mologic test was failing Porton D process on the catastrophic scale? If not and you still think we have gold test, say it now and say it loud! #ODX
And please @Omega_ODX #ODX do not believe in good intentions of UKGov. All they do is play for time. For you it’s the last chance you did not expect to get again. Make good use of it!!!
Read 4 tweets
1/8
Here in Germany, we have already reached the point that my local grocery shop is selling rapid antigen tests.

Their product of choice is Hotgen, produced by a company out of Beijing.

Claims SENS 95.3% and SPEC 99.13% with the anterior nasal method.

#AVCT #ABDX #ODX
2/
There is now an unbelievable number of different products on the market in Germany, with the most popular being fairly local names, Roche and Siemens.

Both of these tests are being employed in school and kindergartens. Both employ nasal swab.

Schools testing twice weekly.
3/
Kindergartens are giving parents two tests per week and encouraging their use.

The Roche test is essentially the SD Biosensor test the Siemens is Healgen. Both of which went through Porton Down but apparently weren't contracted.

Having spent so long studying the market,
Read 8 tweets
Quick recap on @avacta #AVCT's #COVID19 LFT.

By the end of next week, the Co intends to have put out a comprehensive TU.

Critically, it will include the sensitivity / specificity of its #COVID19 LFT for the first time. Analytical data collected so far suggests that it'll...1/14
...be the most accurate LFT in the world. However, it is not a given that analytical data will be replicated in the clinical data. Likely, but not definite.

Let's assume it IS replicated. #AVCT will CE Mark its LFT next month, and immediately begin selling it.

2/14
@avacta #AVCT does not have its own manufacturing capacity (yet). It will be contracting manufacturers to make its test.

It's lined up @Abingdon_Health #ABDX, @bbi_solutions and @mologic / GAD, and is working with @OmegaDiagnostic #ODX too (although not publicly announced). 3/14
Read 14 tweets
UK micro > small cap 🔬 snap shot

#Novacyt
Sales - £277m
Cash - £92m
COVID prods on sale - 10+
Market Cap - £565m

#Abingdon, #BBI, #Omega, #Avacta, #GeneDrive (#GDR) & #Yourgene

Sales - £28m > £30m (Yourgene £18>£20m)
Cash - 🤔
COVID prods on sale - 3🤔
Market Cap - £761m Image
There's a margin of error to account for BBI accounts which aren't public, awaiting GeneDrive which reports 31/03, Avacta account were published 23/01 last yr.

Say £5m tops. Small fry when you consider imbalance of collective market capitalisations.
AIM 2020 Top % Risers (cash / Mcap)
#NCYT - £91.8m / £553m
#AAA - £10.2m / £204m
#SNG - £10.9m / £305m
#GGP - £6m / £983m
#EQT - €1.7m / £156m
#SVE - £118k / £13m
#EUA - £50.8k / £759m
#MNO - £1.43m / £25m
#PHE - £5m / £306m
#OMI - £7.6m / £51m

*info as per latest relevant RNS Image
Read 10 tweets
An extraordinary day. Firstly, fabulous initial data from Pfizer's vaccine, demonstrating it's 90% effective. An immense scientific breakthrough and a boon for humanity.

From an investment perspective (the raison d'être of this account!): a day of joy and misery, equally! 1/16
Global indices absolutely rocketed - 27/100 FTSE100 Cos ended the session at 10%+. Most sectors were up, whilst precious metals miners and #COVID19-centric stocks got obliterated. The latter group included treatment and testing stocks, and at home/online entertainment/living 2/16
Personally, my PF took an almighty spanking, owing to #AVCT being my largest position by a distance, and also having recently opened a position in #SNG.

A high quality vaccine was always the key risk to #COVID19 plays, but for me, that has always been a medium term risk. 3/16
Read 16 tweets
NOVACYT

Professor Jo Martin in the picture below is hard at work finishing off the report and recommendations for NPT Care Home testing in the UK.

She is one of the UK Gov's advisors at the DHSC and Head of Pathology.

Here she is with #NCYT Q16.

#ALNOV #ODX #GDR #AVCT #SNG Image
The Novacyt Q16 she's holding in her palm is small yet it can perform 14 Gold Standard tests in an hour (average throughput of around 4mins per test).

However the CEO said last week they have a NEW innovation for it. They're going speed it up and simplify it even more.
This was one of the CEO's typically understated additions - where he has a habit of sneaking in massive bombshells without the market noticing.

This new update coming for the Q16's & Q32's turns these amazing devices..
Read 9 tweets
NOVACYT

Market cap, as pointed out by a hedge fund last night, is

"Currently lower than expected cash in bank come June 2021"

Find ANY other company on the stock market in that situation and post here. #NCYT is a once in a generation stock.

#ALNOV #ODX #AVCT #GDR #SNG #N4P
If investors don't understand what that means, it means that Novacyt will eventually re-rate come 2021, and it will have a market capitalisation of 1 to 2 billion and keep growing.

To miss something so obvious, you will never have any credibility
Take a look at diagnostics companies, their revenues, and their market caps:

pharmashots.com/16995/top-20-d…
Read 4 tweets
1/11
Another interesting #AVCT slide I liked, which again supports what I have been saying today.

"Avacta is addressing the very significant COVID-19 testing opportunity in UK first and will continue to scale manufacturing to meet global demand"

What a lovely sentence that is.
2/11
Particularly when they go on to talk about 30m people testing themselves once a week, delivering 120m tests per month.

That's just one market.

"Therefore the commercial opportunity form Avacta is determined by supply capacity and not demand"

Lovely sentence mark 2
3/11
Yes they talk about self testing but until that is available (post field studies etc), business can be encouraged to take up the strain. Such things as tax credits etc come to mind, meaning a shoot for such a number, starts when professional use gets the green light.
Read 11 tweets
(1/2)

US alone needs to be testing 20m a day by July, in order to re-open its economy.

Circa 600m a month.

"The US will be able to test 8m per month by May."

Abbots plans to ship 20m antibody tests in June. Not per day, per month.

#AVCT #ODX #GDR

cnbc.com/2020/04/29/cor…
(2/2)

So barely scratching the surface as they would effectively be giving upping US testing capabilities to 'just' 28m a month.

So just the 572m short then and that's just the US.

No 1 company can answer this call, it is likely going to take them all.

#AVCT #GDR #ODX
From today's #AVCT RNS ;

"A consensus view is building around the world that hundreds of millions of COVID-19 tests are going to be required per month for a long period"

Like I said, no 1 company can answer this call, it is likely going to take them all.

Bigger boat anyone?
Read 3 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!